ClinicalTrials.gg
Status unknownNCT01226251StriptestUpdated Oct 2, 2012

New "in Vitro" Diagnostic Test for Oral Malodour

An observational study in Halitosis, sponsored by Universitaire Ziekenhuizen KU Leuven. Status unknown at 1 site in Belgium. Open to participants aged 18 Years to 75 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2012-10-02.

Sponsored by Universitaire Ziekenhuizen KU Leuven · Observational

The sponsor has not verified this record recently (last verified Oct 2012), so the status shown — last known as Recruiting — may be out of date.
Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
150
Ages
18 Years to 75 Years
Sex
All
01

Study summary

This study will assess the ability of a first prototype (strip) of a new chair side test to detect oral malodour. The strip is based on a new enzymatic reaction able to detect amines in saliva. Previous studies already showed significant correlations between oral malodor and the levels of amines in saliva. The limitation in their use as markers of oral malodour is the fact that the detection is usually carried out by complex techniques (High Performance Liquid Chromatography(HPLC)and Solid-Phase Micro Extraction-Gas Chromatography/Mass Spectrometry (SPME-GC/MS)). The results of the new enzymatic reaction can be evaluated by means of a colorimetric scale without necessity of extra apparatus.

The study will be carried out with volunteers recruited at a multidisciplinary consultation for bad breath, organized at the University Hospital Leuven, Belgium.

The paper strip will be used before the routine evaluation (organoleptic score (OS), the gold standard method for the diagnosis of halitosis and the level of volatile sulphur compounds (VSC), the most used adjunct tool to diagnose halitosis).

The results of the new chair side test (strip) will be correlated with the OS and VSC measurements (OralChroma™, Halimeter®). The sensitivity, specificity and positive and negative predicted values of the new chair side test will be calculated. The cut-off values for a yes/no test will be determined. The meaning of color scores will be analyzed to assign a meaningful outcome to each score with relation to odor intensity.

02

Conditions studied

  • Halitosis

Browse trials for

Keywords

  • oral malodour
  • halitosis
  • Subjects consulting a bad breath clinic
03

In context

Halitosis

90 studies on the registry are indexed under Halitosis; 18 are open to participants now.

This study's planned enrollment of 150 is above the median of 89 across 12 observational studies indexed under Halitosis.

Browse Halitosis studies →

Lead sponsor

Universitaire Ziekenhuizen KU Leuven is the lead sponsor of 958 studies on the registry; 263 are open to participants now.

Of its 5 completed or terminated interventional studies of FDA-regulated products, 0 (0%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 75 Years
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Non-probability sample

Study population

Hundred consecutive adult subjects consulting the bad breath clinic who meet the inclusion criteria.

Number of volunteers extended to 150 in March 2012 (Amendment Research Agreement)

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Adults (≥18 years
  • With no evidence of bad breath or bad breath of intra-oral cause (oral malodour)
  • Non-smokers or smokers from whom the organoleptic evaluation can be performed (no interference from smoke odour)

Exclusion criteria

Exclusion Criteria:

  • Smokers from whom the organoleptic evaluation can not be performed because of interference from smoke odour
  • Presence of active caries
  • Presence of sinusitis or any other Oro-pharyngeal problem
  • On medications which can cause malodour
  • Reduced salivary flow due to pathological reasons (e.g. Sjögren syndrome)
  • Any oral pathophysiological condition or any oral disease (e.g. oral cancer, mucositis)
  • Pregnancy and nursing
  • Situation considered not compatible with the study according to the investigator's opinion; the latter includes: persons under homeopathic therapy, patients who used antibiotics during the 2 months before the study, patients frequently using chewing gum, patients under corticosteroids or other serious medications.
05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
150 participants (estimated)

Groups and cohorts

  • Healthy adults

    Subjects consulting a bad breath clinic at the Department of Periodontology, KULeuven

    Device: In vitro chair side test

Interventions

  • DeviceIn vitro chair side test

    Colour evaluation of a strip

    Also known as: Strip tes for oral malodour GABA (still confidential)

06

What researchers measure

Primary outcomes

  1. Colour evaluation of the new chair side test

    The colour will be assessed before all the other test and after 4 minutes of contact between the strip and the saliva of the volunteer.

    Time frame: Once (during the first consult to the clinic)

Secondary outcomes

  1. Organoleptic evaluation (OS)

    The OS will be determined by a trained and calibrated judge as described in the literature. Briefly, patients will be asked to count from one to eleven and the judge rated the exhaled air on a 0 to 5 score ( 0 represents absence of odour, 1 is given for barely noticeable odour, 2 for slight malodor, 3 for moderate malodor, 4 for strong malodor and 5 for severe malodor). The judge will also evaluate nasal breath in order to exclude extra-oral causes of halitosis and the odor of a sample of the tongue coating, if present.

    Time frame: Once (during the first consult to the clinic)

  2. Total VSC reading

    The global concentration of sulphur containing compounds will be measured using a portable breath analyzer (Halimeter®, Interscan cooperation, Chatsworth, US. The maximum level attained (ppb) is determined by direct readings from the analog scale of the monitor.

    Time frame: Once (during the first consult to the clinic)

  3. Specific VSC readings

    Hydrogen sulphide, methyl mercaptan and dimethyl sulphide will be measured using a commercially available system (OralChroma™, Abilit Corporation; Osaka City, Japan). This portable gas chromatograph is equipped with an indium oxide semiconductor gas sensor. The concentration values (ppbv) of the three gases will be recorded.

    Time frame: Once (during the first consult to the clinic)

07

Study locations

1 of 1 sites recruiting
  • Department of Periodontology, Faculty of Dentistry, Catholic University of Leuven
    Leuven, 3000, Belgium
    Recruiting
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Oct 2, 2012, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT01226251
Responsible party
Marc Quirynen (PhD DDS, Universitaire Ziekenhuizen KU Leuven) — Principal investigator
First posted
Oct 22, 2010
Start date
Jan 2011
Primary completion
Dec 2012 (estimated)
Completion
Mar 2013 (estimated)
Last update
Oct 2, 2012

Study contacts

Marc Quirynen, PhD, DDS
Contact
marc.quirynen@uzleuven.be
+32 16 33 24 85
Jesica Dadamio, Master Bioch
Contact
jesica.dadamio@med.kuleuven.be
+32 16 34 72 82
Marc Quirynen, PhD, DDS
principal investigator · Universitaire Ziekenhuizen KU Leuven

Oversight

Data monitoring committee
Yes
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Oct 2012. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion